| Drug Name |
Cefpodoxime proxetil |
| Drug ID |
BADD_D00396 |
| Description |
Cefpodoxime is an oral third generation cephalosporin antibiotic with effectiveness against most Gram positive and Gram negative bacteria. Commonly used to treat acute otitis media, pharyngitis, and sinusitis, cefpodoxime proxetil is a prodrug which is absorbed and de-esterified by the intestinal mucosa to Cefpodoxime. |
| Indications and Usage |
For the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J01DD13 |
| DrugBank ID |
DB01416
|
| KEGG ID |
D00920
|
| MeSH ID |
C053267
|
| PubChem ID |
6321414
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
61788-5000; 65862-095; 16714-403; 16714-394; 69043-006; 65862-381; 16714-402; 65862-140; 69043-007; 65862-096; 0781-5439; 64980-403; 16714-395; 65862-141; 55289-393; 0781-5438; 63785-112; 64980-402; 57297-100 |
| Synonyms |
cefpodoxime proxetil | 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate | Vantin | U 76252 | U-76,252 | cephalosporin 807 | CS 807 | CS-807 | Doxef |
